Trophoblast

From Embryology
Revision as of 12:52, 21 August 2014 by Z8600021 (talk | contribs)
Embryology - 29 Mar 2024    Facebook link Pinterest link Twitter link  Expand to Translate  
Google Translate - select your language from the list shown below (this will open a new external page)

العربية | català | 中文 | 中國傳統的 | français | Deutsche | עִברִית | हिंदी | bahasa Indonesia | italiano | 日本語 | 한국어 | မြန်မာ | Pilipino | Polskie | português | ਪੰਜਾਬੀ ਦੇ | Română | русский | Español | Swahili | Svensk | ไทย | Türkçe | اردو | ייִדיש | Tiếng Việt    These external translations are automated and may not be accurate. (More? About Translations)

Introduction

Human Blastocyst (day 5), trophoblast cells form the peripheral flattened epithelial layer of cells directly under the zona pellucida.[1]
Mouse blastocyst labelled with trophoblast marker.[2]

(Greek, trophe = "nutrition" and -blast, a primordial cell) During early development the trophoblast cells have an important contribution to extraembryonic tissues (fetal placenta and membranes) and processes of early development (adplantation, implantation and endocrine support of pregnancy).

In humans, week 1 blastocyst formation the outer layer of cells (adjacent to the zona pellucida) form a flat squamous epithelial layer of cells, the trophoblast layer. Week 2 following blastocyst hatching the trophoblast layer is involved with initial adhesion to the uterine wall and subsequent implantation within the wall. During this period the trophoblast layer differentiates into two distinct layers (syncitiotrophoblast and cytotrophoblast).



Links: Blastocyst | Implantation | Week 2 | Week 3 | Placenta Development | Trophoblast - Protein Expression

Some Recent Findings

  • Cell fusion induced by ERVWE1 or measles virus causes cellular senescence.[3] "Cellular senescence limits proliferation of potentially detrimental cells, preventing tumorigenesis and restricting tissue damage. However, the function of senescence in nonpathological conditions is unknown. We found that the human placental syncytiotrophoblast exhibited the phenotype and expressed molecular markers of cellular senescence. During embryonic development, ERVWE1-mediated cell fusion results in formation of the syncytiotrophoblast, which serves as the maternal/fetal interface at the placenta."
  • Early Expression of Pregnancy-Specific Glycoprotein 22 (PSG22) by Trophoblast Cells Modulates Angiogenesis in Mice[4] "Mouse and human pregnancy-specific glycoproteins (PSG) are known to exert immunomodulatory functions during pregnancy by inducing maternal leukocytes to secrete anti-inflammatory cytokines that promote a tolerogenic decidual microenvironment. Many such anti-inflammatory mediators also function as pro-angiogenic factors, which, along with the reported association of -murine PSG - with the uterine vasculature, suggest that PSG may contribute to the vascular adaptations necessary for successful implantation and placental development. ...Therefore, our findings indicate that despite the independent evolution and expansion of human and rodent PSG, members in both families have conserved functions, which include their ability to induce anti-inflammatory cytokines and pro-angiogenic factors as well as to induce the formation of capillary structures by endothelial cells. In summary, our results indicate that PSG22, the most abundant PSG expressed during mouse early pregnancy, is likely a major contributor to the establishment of a successful pregnancy."
  • Involvement of transcription factor NR2F2 in human trophoblast differentiation[5] "During the in vitro differentiation of human villous cytotrophoblast (CTB) cells to a syncytiotrophoblast (STB) phenotype, mRNA levels for the nuclear hormone receptor NR2F2 (ARP-1, COUP-TFII) increase rapidly, reaching a peak at day 1 of differentiation that is 8.8-fold greater than that in undifferentiated CTB cells."
  • Angiogenic growth factors[6] "Fourteen angiogenic growth factors were measured by multiplex growth factor analysis or ELISA in tissue culture supernatants from EVT and CTB from pregnancies at 8-10 and 12-14 weeks' gestation. Gestational age and cell type differences were observed. Extravillous trophoblast (EVT) and villous cytotrophoblast (CTB) are major producers of angiogenic growth factors that likely contribute to placental vascular development and spiral artery remodeling."
More recent papers
Mark Hill.jpg
PubMed logo.gif

This table allows an automated computer search of the external PubMed database using the listed "Search term" text link.

  • This search now requires a manual link as the original PubMed extension has been disabled.
  • The displayed list of references do not reflect any editorial selection of material based on content or relevance.
  • References also appear on this list based upon the date of the actual page viewing.


References listed on the rest of the content page and the associated discussion page (listed under the publication year sub-headings) do include some editorial selection based upon both relevance and availability.

More? References | Discussion Page | Journal Searches | 2019 References | 2020 References

Search term: Trophoblast

<pubmed limit=5>Trophoblast</pubmed>

Trophoblast and Placental Villi

Early placental structure.jpg

Early placental development cartoon showing trophoblast contribution to placental villi.[7]

Legend

  • SYN - syncytiotrophoblasts
  • sCTB - subsyncytial cytotrophoblasts (this layer grows increasingly discontinuous in later trimesters)
  • EVT - extravillous cytotrophoblasts (anchor the villous tree in the decidua)

Cytotrophoblasts

Hyperglycosylated human Chorionic Gonadotropin (hCG) promotes the growth of cytotrophoblast cells and the endometrial invasion by these cells during implantation.[8]

Extravillous Cytotrophoblasts

Maintain open maternal spiral arteries emptying into the maternal lacunae[9]

Syncytiotrophoblasts

File:Cytotrophoblast to syncytiotrophoblast cartoon
  • form by fusion of rapidly dividing cytotrophoblast cells
  • secrete proteolytic enzymes, enzymes break down extracellular matrix around cells
  • Allow passage of blastocyst into endometrial wall, totally surround the blastocyst
  • generate spaces, lacunae, that fill with maternal blood
  • secrete Human Chorionic Gonadotropin (hCG), hormone, maintains decidua and Corpus Luteum, basis of pregnancy diagnostic test, present in urine is diagnostic of pregnancy
    • Later in development placenta will secrete hCG

Cell–cell Fusion Activity

Two pairs of envelope genes of retroviral origin, syncytins, have fusogenic properties. Human endogenous retroviruses (HERVs) make up about 8% of the human genome. Recent study has shown that placentae from intrauterine growth restriction have impaired cell fusion and differentiation that correlates with reduced levels of HERV envelope genes.[10]

Human - syncytin 1 and syncytin 2

  • Syncytin 2 is an envelope gene from the human endogenous retrovirus FRD (HERV-FRD)[11]
  • Syncytin 2 receptor is Major Facilitator Superfamily Domain Containing 2 (MFSD2) (at chromosomal position 1p34.2)
  • belongs to family of presumptive carbohydrate transporters with 10-12 membrane-spanning domains
  • Syncytin 1 (-FRD) receptor is ASCT-1/-2

Mouse - syncytin A and syncytin B

  • syncytin A is essential for trophoblast cell differentiation and syncytiotrophoblast morphogenesis[12]
Links: OMIM Syncytin-2

Human Chorionic Gonadotropin

hCG sources - produced by villous syncytiotrophoblast cells, hyperglycosylated hCG produced by cytotrophoblast cells, free beta-subunit made by multiple primary non-trophoblastic malignancies, and pituitary hCG made by the gonadotrope cells of the anterior pituitary.

  • levels peak at 8 to 10 weeks of pregnancy, then decline and are lower for rest of pregnancy
0-1 week: 0-50 mIU/ml 

1-2 weeks: 40-300 mIU/ml
3-4 weeks: 500-6,000 mIU/ml
1-2 months: 5,000-200,000 mIU/ml
2-3 months: 10,000-100,000 mIU/ml
2nd trimester: 3,000-50,000 mIU/ml
3rd trimester: 1,000-50,000 mIU/ml

Non-pregnant females: <5.0 mIU/ml Postmenopausal females: <9.5 mIU/ml

HLA-G

An acronym for histocompatibility antigen, class I, G (also called: Human Leukocyte Antigen G, (HLA-6.0; HLA60, T-CELL A LOCUS, TCA) and is expressed on placental cytotrophoblast cells and other adult tissues. This distinct tissue distribution differs from the other HLA antigens (HLA-A, HLA-B, HLA-C) leading to the description as a non-classical class I antigen. May have a role in protecting the fetus from the maternal immune response.

Human gene is located at 6p22.1 and there exist several protein isoforms from alternative splicing of messenger RNAs, membrane-bound isoforms (HLA-G 1-4) and soluble soluble (HLA-G 5-6)[13]. The molecule is a heterodimer consisting of both a heavy chain and a light chain (beta-2 microglobulin). The membrane-bound isoform heavy chain is anchored in the membrane and increased expression of the soluble form is related to higher implantation rates. Changes in HLA-G expression have been associated with increased miscarriage rates.[14] Killer cell immunoglobulin-like receptor (KIR) 2DL4 (KIR2DL4) has been shown to act as a receptor for the soluble HLA-G, leading to a stimulation of resting natural killer (NK) cells.[15]


Links: HLA-G | OMIM142871

Trophoblast Cell Lines

A useful component of current placentation and trophoblast research are a number of trophoblast cell lines that have been derived from a number of different sources including term placenta, choriocarcinomas and transformation of primary isolated cells. BeWo cell line is the earliest human choriocarcinoma, established in 1968[16]. Most appear to be examples of extravillous trophoblast cells.

  • BeWo - human choriocarcinoma[16], hypotetraploid (modal number = 86; range = 71 to 178) (ATCC CCL-98)
  • JEG-3 - choriocarcinoma HTR8/SVneo a transformed extravillous trophoblast line
  • SGHPL-4 - [17]
  • TEV-1 - (HPV16) E6/E7 infection first-trimester extravillous trophoblast cell line[18]
  • HChEpC1b - retroviral infection by E6/E7/hTERT[19]


History

Ambrosius Arnold Willem Hubrecht (1853 – 1915)

The name "Trophoblast" was used for the first time by Ambrosius Arnold Willem Hubrecht (1853 – 1915) at the meeting of the Anatomical Congress at Wiirzburg in 1888, and its earliest definition is found in the report of that meeting in Nos. 17 and 18 of the Anatomischer Anzeiger, Bd. III. "We there read, concerning a very early stage of the hedgehog (p. 510) : Die aussere Wand der Keimblase ist verdickt (drei bis vierschichtig) und besitzt wabige Lacunen. Fur diese aussere (epiblastische) Schicht sei der. Name Trophoblast gewahlt."



Links: The Trophoblast - A Rejoinder (1904) | Ambrosius Arnold Willem Hubrecht | Hubrecht Collection | Embryologists | Embryology History

Abnormalities

Hydatidiform Mole

Hydatidiform Mole

A type of placental abnormality when only the conceptus trophoblast layers proliferates and not the embryoblast, no embryo develops, this is called a "hydatidiform mole", which is due to the continuing presence of the trophoblastic layer, this abnormal conceptus can also implant in the uterus. The trophoblast cells will secrete human chorionic gonadotropin (hCG), as in a normal pregnancy, and may appear maternally and by pregnancy test to be "normal". Prenatal diagnosis by ultrasound analysis demonstrates the absence of a embryo.

There are several forms of hydatidiform mole: partial mole, complete mole and persistent gestational trophoblastic tumor. Many of these tumours arise from a haploid sperm fertilizing an egg without a female pronucleus (the alternative form, an embryo without sperm contribution, is called parthenogenesis). The tumour has a "grape-like" placental appearance without enclosed embryo formation. Following a first molar pregnancy, there is approximately a 1% risk of a second molar pregnancy.

This topic is also covered in Placenta - Abnormalities

Trophoblast Infections

References

  1. <pubmed>19924284</pubmed>| PMC2773928 | PLoS One
  2. <pubmed>16681851</pubmed>| PMC1479373 | J Transl Med.
  3. <pubmed>24186980</pubmed>| Genes Dev.
  4. <pubmed>22423048</pubmed>
  5. <pubmed>20195529</pubmed>| PLoS One
  6. <pubmed>20338637</pubmed>
  7. <pubmed>20107601</pubmed>| PLoS
  8. <pubmed>20735820</pubmed>
  9. <pubmed>20359743</pubmed>
  10. <pubmed>20664994</pubmed>
  11. <pubmed>18988732</pubmed>| PNAS
  12. <pubmed>19564597</pubmed>
  13. <pubmed>16339579</pubmed>
  14. <pubmed>24557735</pubmed>
  15. <pubmed>16366734</pubmed>
  16. 16.0 16.1 <pubmed>5753554</pubmed>
  17. <pubmed>16226120</pubmed>
  18. <pubmed>15866109</pubmed>
  19. <pubmed>19148547</pubmed>
  20. <pubmed>19265152</pubmed>
  21. <pubmed>19115001</pubmed>
  22. <pubmed>18599257</pubmed>


Reviews

<pubmed>19876840</pubmed>

Articles

<pubmed>20081188</pubmed> <pubmed>20033790</pubmed> <pubmed>19617545</pubmed> <pubmed>19564597</pubmed> <pubmed>19582159</pubmed>

Search PubMed

Search October 2010

  • Syncytiotrophoblast - All (10230) Review (1104) Free Full Text (2508)
  • Cytotrophoblast - All (9828) Review (1062) Free Full Text (2401)


Search Pubmed: Trophoblast | syncytiotrophoblast | cytotrophoblast |


Embryo Week: Week 1 | Week 2 | Week 3 | Week 4 | Week 5 | Week 6 | Week 7 | Week 8 | Week 9


Carnegie Stages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | About Stages | Timeline


Glossary Links

Glossary: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Numbers | Symbols | Term Link



Cite this page: Hill, M.A. (2024, March 29) Embryology Trophoblast. Retrieved from https://embryology.med.unsw.edu.au/embryology/index.php/Trophoblast

What Links Here?
© Dr Mark Hill 2024, UNSW Embryology ISBN: 978 0 7334 2609 4 - UNSW CRICOS Provider Code No. 00098G